Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]
This document reports an early-phase 1 study of Iberdomide (CC-220) in combination with Elotuzumab and Dexamethasone for relapsed/refractory…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE) [Phase 2]
Phase 2 clinical trial evaluating minimal residual disease–driven deferral of transplant in dysproteinemia, including multiple myeloma and A…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)
A recruiting clinical study evaluating whether a pragmatic geriatric assessment before CAR-T cell therapy or bispecific antibody treatment c…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Dietary Study for People With Multiple Myeloma [NA]
An ongoing dietary-study trial for people with multiple myeloma is currently recruiting, sponsored by Memorial Sloan Kettering Cancer Center…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 2]
A Phase 2 study assessing subcutaneous isatuximab in combination with carfilzomib and dexamethasone for adults with relapsed/refractory mult…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma [NA]
A clinical trial update indicates that Nanjing Legend Biotech's LCAR-F33S is being studied for relapsed/refractory multiple myeloma and is c…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma [NA]
This clinical trial update describes a study evaluating the quality of life of caregivers of patients with multiple myeloma. The study statu…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies [NA]
This clinical trial compares reduced-dose apixaban and rivaroxaban against low-molecular-weight heparin for venous thromboembolism managemen…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Randomised Controlled Trial of Artificial Intelligence-assisted Health Education [NA]
A randomized controlled trial to assess the effectiveness of artificial intelligence–assisted health education, sponsored by Zhongnan Hospit…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma [Phase 1]
A Phase 1 trial evaluating three venetoclax-based regimens (Ven-Rd, Ven-Dd, Ven-DRd) in multiple myeloma. The study is currently recruiting …
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Prehabilitation Feasibility Among Older Adults Undergoing Transplantation [NA]
This clinical trial update reports ongoing recruitment for a feasibility study evaluating prehabilitation in older adults with multiple myel…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 [Phase 2]
Phase 2 clinical trial update for MajesTEC-5 in multiple myeloma, currently recruiting at University of Heidelberg Medical Center.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) [NA]
This clinical trial update describes a telemedicine and mobile health symptom management intervention for advanced cancer patients (FOCUS), …
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT) [Phase 2]
A Phase 2 trial is evaluating the combination of plinabulin and pegfilgrastim in people with multiple myeloma undergoing autologous stem cel…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: ICOPE Program Feasibility in the Management of Myeloma Patients [NA]
A feasibility study evaluating the ICOPE program for managing frailty in patients with multiple myeloma. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients
Real-world immunotherapy trial for Chinese patients with newly diagnosed multiple myeloma is currently recruiting. Sponsor is Peking Univers…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Selinexor and Backbone Treatments of Multiple Myeloma Patients [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating selinexor with backbone therapies for multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma [Phase 2]
This Phase 2 clinical trial is evaluating belantamab mafodotin in combination with carfilzomib, pomalidomide, and dexamethasone for relapsed…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis [Phase 1]
This clinical trial update reports a Phase 1 study of romosozumab in women with osteoporosis and multiple myeloma, with the study currently …
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma [EARLY_Phase 1]
This document describes an EARLY_PHASE1 clinical trial evaluating LVIVO-TaVec200 for relapsed/refractory multiple myeloma, which is currentl…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Cevostamab Following CAR T Cell Therapy for RRMM [Phase 2]
This update reports on a Phase 2 clinical trial evaluating Cevostamab after CAR T cell therapy in relapsed or refractory multiple myeloma, c…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies [Phase 1, Phase 2]
A Phase 1/2 study is evaluating CCS1477 (Inobrodib) in multiple hematologic malignancies and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple Myeloma [Phase 1]
Phase 1 open-label trial of belantamab mafodotin in high-risk smoldering multiple myeloma is ongoing, with an extension cohort at a single c…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse [Phase 2]
A Phase 2 trial evaluating subcutaneous talquetamab in elderly patients with early-relapse multiple myeloma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM [Phase 2]
This Phase 2 trial evaluates a four-drug regimen (lenalidomide, ixazomib, dexamethasone, and daratumumab) in transplant-ineligible patients …